Form 4 Filing for Immunome Inc. - Officer Stock Transactions

This filing details stock transactions by Robert Lechleider, Chief Medical Officer of Immunome Inc. On June 25, 2026, Lechleider acquired 55,000 shares of Common Stock through the exercise of an employee stock option at a price of $0.00 per share, with an underlying value of $8.73 per share. This transaction increased his post-transaction shares to 70,805. Concurrently, he disposed of 40,580 shares at a weighted average price of $19.56 and 14,420 shares at a weighted average price of $20.66. These sales were executed under a Rule 10b5-1 trading plan. Footnotes provide further details on the sales price ranges and the vesting schedule of the stock options. The option exercised was granted with an exercise price of $8.73.